Georgia Healthcare Group PLC Annual Report 2018 Strategic Report New services continued Bone marrow transplantation In 2018, we introduced a comprehensive treatment, a bone marrow transplant, for patients with blood and bone marrow disorders at our High Technology Medical Centre University Clinic (”HTMC”). Before 2018, the service was not available in Georgia and patients with diagnoses such as leukaemia, severe blood diseases or multiple myeloma had to undergo treatment abroad. We, as a Group, are proud to have successfully filled the long-existing service gap in the Georgian market and are now the first and only provider of bone marrow transplants in the country, helping the local population avoid higher costs of getting treatment abroad. We have formed partnerships with foreign hospitals and our expert haematologist and oncologists work hand-in-hand with the foreign specialists to perform comprehensive procedures and treat many types of haematological or blood-related malignancies such as leukaemia, lymphoma as well as rare solid-organ tumours. The investment required for introduction of this service totalled around GEL 2.0 million. Through joint efforts of our haematology team, extensively trained in Israel, and Israeli doctors, 50 adult autologous bone marrow transplants were performed at HTMC in 2018. As a next step, we are going to introduce bone marrow transplantation for the paediatric patients who suffer from leukemia or other blood, plasma or bone marrow diseases. Neonatology GHG is committed to developing neonatal services in the country, one of the most important fields of medicine, throughout its network. In recent years, we have invested around GEL 2.4 million to add more than 60 beds and upgrade neonatal units with modern medical equipment in our Tbilisi, Kutaisi, Batumi and Zugdidi hospitals. For many years, the country has suffered from a shortage of and poor quality of neonatal beds. Infants with various pathologies have often faced fatal outcomes. Investing in this medical field has resulted in improved statistics, reducing the infant mortality rate by more than half over the last decade. By increasing the quality and the number of neonatal beds from 140 to 205 in the past five years, GHG has gradually closed the existing service gap in the country. Nowadays, the premature infants or infants with other pathologies have easy and fast access to high-quality neonatal services. This field of medicine has proven one of the most successful for the Group. The Newborn Intensive Therapy Department at Iashvili Tertiary Referral Hospital offers exceptional service and holds a leading position in the country. The department is led by an expat Georgian doctor, trained in US. This is the only department in the country that receives newborns with most severe complications. Our neonatal team does its best to save hundreds of babies each year. Our collaboration with the Mayo Clinic has highly contributed to the development of the field. Experts from Mayo conducted trainings for our personnel and were engaged in developing trainers to provide further training and continuous development for our doctors. 20